Employees: 00 (2023.0)Legal category: 5485Size: PMECreation date: 2014-08-05 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA BAULE-ESCOUBLAC (44500), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
2B PHARMACIE : revenue, balance sheet and financial ratios
2B PHARMACIE is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA BAULE-ESCOUBLAC (44500),
this company of category PME
shows in 2022 a net income positive of 63 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - 2B PHARMACIE (SIREN 804463867)
Indicator
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
63 474 €
6 803 €
37 647 €
121 650 €
154 370 €
89 067 €
28 515 €
-51 616 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2022, 2B PHARMACIE generates positive net income of 63 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
63 474 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 459%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 16%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
458.658%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
16.012%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
Debt ratio
-97209.592
5518.224
1194.535
465.141
302.61
337.52
579.074
458.658
Financial autonomy
-0.086
1.478
6.472
14.881
22.142
21.065
13.646
16.012
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
458.662022
2020
2021
2022
Q1: 24.51
Med: 74.73
Q3: 182.48
Average
In 2022, the debt ratio of 2B PHARMACIE (458.66) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
16.01%2022
2020
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.62%
Average
In 2022, the financial autonomy of 2B PHARMACIE (16.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 70.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
70.854
Liquidity indicators evolution 2B PHARMACIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
80.323
65.692
73.693
96.591
117.136
304.404
129.847
70.854
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
70.852022
2020
2021
2022
Q1: 145.16
Med: 199.46
Q3: 274.98
Watch-62 pts over 3 years
In 2022, the liquidity ratio of 2B PHARMACIE (70.85) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of 2B PHARMACIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of 2B PHARMACIE is estimated at
746 867 €
(range 502 043€ - 1 120 162€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
502k€746k€1120k€
746 867 €Range: 502 043€ - 1 120 162€
NAF 5 année 2022
Valuation method used
Net Income Multiple
63 474 €
×
11.8x
=746 867 €
Range: 502 043€ - 1 120 162€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare 2B PHARMACIE with other companies in the same sector:
The revenue of 2B PHARMACIE is not publicly disclosed (confidential accounts filed with INPI).
Is 2B PHARMACIE profitable?
Yes, 2B PHARMACIE generated a net profit of 63 k€ in 2022.
Where is the headquarters of 2B PHARMACIE ?
The headquarters of 2B PHARMACIE is located in LA BAULE-ESCOUBLAC (44500), in the department Loire-Atlantique.
Where to find the tax return of 2B PHARMACIE ?
The tax return of 2B PHARMACIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does 2B PHARMACIE operate?
2B PHARMACIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart